Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | GGT1 | P19440 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28316445 | 0.96 | TSHR (0.50) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL28314438 | 0.96 | TSHR (0.50) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL52160 | 0.96 | — | — | |
| SCHEMBL11587164 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL105855 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL28315587 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| Hydrochloric Acid SCHEMBL808934 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| Hydrochloric Acid SCHEMBL4682921 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL106724 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL28316146 | 0.92 | TSHR (0.53) | TSHRALDH1A1CYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110172019-A | The metal salt of malonic acid as the nucleating additive for crystalline thermoplastic | 印度石油有限公司 | 2019-08-27 | — | — | CN | claimed |
| US-20190256683-A1 | METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS | INDIAN OIL CORPORATION LIMITED (IN) | 2019-08-22 | — | — | US | claimed |
| EP-3527616-A1 | METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS | INDIAN OIL CORPORATION Ltd. (IN) | 2019-08-21 | — | — | EP | claimed |
| US-20160046582-A1 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2016-02-18 | — | — | US | claimed |
| EP-2970129-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2016-01-20 | — | — | EP | claimed |
| WO-2014153145-A2 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2014-09-25 | — | — | WO | claimed |
| US-5756594-A | CATALYTIC POLYMERIZATION OF ALDEHYDE CARBOXYLATE MONOMER TO FORM POLYACETAL AND CROSSLINKING WITH POLYVINYL ETHERS, DIESTERS, DIEPOXIDES, ANHYDRIDES, DINITRILES AND DIACYL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | claimed |
| WO-2024200617-A1 | PROCESS AND INTERMEDIATES FOR PREPARING A DRUG FOR THE TREATMENT OF UREA CYCLE DISORDERS | DIPHARMA FRANCIS S.R.L. (IT) | 2024-10-03 | — | — | WO | disclosed |
| EP-3527616-B1 | METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS | INDIAN OIL CORP LTD (IN) | 2024-02-07 | — | — | EP | disclosed |
| CN-109477829-B | Nuclear magnetic resonance analysis method for glycosaminoglycan, heparin and derivatives thereof | 罗维药物实验室股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-108475822-B | Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same | 斯泰拉化工公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-110172019-B | Metal salts of malonic acid as nucleating additives for crystalline thermoplastics | 印度石油有限公司 | 2022-03-04 | — | — | CN | disclosed |
| US-11180630-B2 | Metal salts of malonic acid as nucleating additives for crystalline thermoplastics | INDIAN OIL CORPORATION LIMITED (IN) | 2021-11-23 | — | — | US | disclosed |
| EP-0256095-A4 | ANTI-INFLAMMATORY CARBOXY PREGNANE DERIVATIVES. | UNIV FLORIDA AGRICULT MECH (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4762919-A | STEROIDS | FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0256095-A1 | ANTI-INFLAMMATORY CARBOXY PREGNANE DERIVATIVES. | UNIV FLORIDA AGRICULT MECH (US) | 1988-02-24 | — | — | EP | disclosed |
| WO-1987005028-A1 | ANTI-INFLAMMATORY CARBOXY PREGNANE DERIVATIVES | FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY (US) | 1987-08-27 | — | — | WO | disclosed |
| US-4689423-A | Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates | WARNER-LAMBERT COMPANY (US) | 1987-08-25 | — | — | US | disclosed |
| US-4643763-A | PLANT GROWTH REGULATORS | ICI AUSTRALIA LIMITED (AU) | 1987-02-17 | — | — | US | disclosed |
| EP-0181692-A2 | Cyclohexane-1,3-dione derivatives, compositions containing them, processes for making them, and their use as herbicides and plant growth regulators | ICI AUSTRALIA LIMITED (AU) | 1986-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190256683-A1 | METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS | NUMA1, MNS1, ME1 | TSHR 4737/4885ALDH1A1 727/4885CYP2D6 2405/4885 |
| US-11180630-B2 | Metal salts of malonic acid as nucleating additives for crystalline thermoplastics | NUMA1, MNS1, ME1 | TSHR 4737/4885ALDH1A1 727/4885CYP2D6 2405/4885 |
| US-20160046582-A1 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | HLA-DRB1, HAAO, RECQL | TSHR 4064/4885ALDH1A1 1585/4885CYP2D6 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.